Rising Medicare Costs for HIV Treatment: Impacts and Solutions
Explore the projected rise of Medicare costs for HIV treatment and the potential strategies to manage these expenses effectively.
Trump Administration Proposes Medicare Drug Pricing Reform
The Trump administration proposes Medicare drug pricing reform aimed at reducing costs for patients and enhancing healthcare affordability. Read on for insights!
New Medicare Regulation Aims to Cut Drug Prices for Hospitals
The new Medicare regulation aims to reduce drug costs for hospitals, predicting $1.1 billion in savings for beneficiaries. Learn more about this significant change.
New HHS Rule Seeks to Cut Drug Prices for Medicare Beneficiaries
The new HHS rule aims to cut drug prices for Medicare beneficiaries, targeting cost savings for hospitals in the 340B program while addressing billing concerns.
Legislation for Capping Prescription Drug Prices in State-Level Insurance Programs
Explore a new legislative model aimed at capping prescription drug prices, enhancing state-funded insurance programs through public feedback and savings validation.
CMS Requests Feedback on PBM Regulation Under CAA 2026
Explore how CMS is regulating Pharmacy Benefit Managers under CAA 2026, seeking feedback on compensation models and data reporting requirements. Act by July 20, 2026!
Regulatory Changes Impacting Medicaid and ACA: An Overview
Explore the regulatory changes under the Trump administration affecting Medicaid and ACA, with implications for coverage accessibility and health care costs.
Healthcare Legislation Updates and AI in Health Policy
Stay updated on the latest healthcare legislation, AI initiatives, and Medicare developments that shape health policy and patient care strategies.
Medicare Drug Price Negotiation: Proposed Rules and Industry Implications
Learn about the proposed Medicare drug price negotiation rule and its implications on the pharmaceutical industry and state regulations.
Federal Regulation Impacting Medicare Drug Pricing Strategies for 2029
Explore the proposed federal regulation for 2029 affecting Medicare pricing strategies for drugs. Understand the implications and upcoming changes in healthcare policy.